Search research articles
Contact Us
Filters
Showing results (241-250 of 343) with videos related to
Page
of 35
Sort By:
The Journal of Rheumatology. Supplement
|
June 2, 2021
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study
William Tillett, Oliver FitzGerald, Laura C Coates, et al.
The Journal of Rheumatology
|
March 2, 2021
Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study
William Tillett, Oliver FitzGerald, Laura C Coates, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2020
Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps
William Tillett, Neil McHugh, Ana-Maria Orbai, et al.
ACR Open Rheumatology
|
May 19, 2026
Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies
Laure Gossec, William Tillett, Laura C Coates, et al.
Current Rheumatology Reports
|
March 14, 2014
Patient involvement in outcome measures for psoriatic arthritis
William Tillett, Ade Adebajo, Mel Brooke, et al.
The Journal of Rheumatology
|
July 17, 2019
Relationship Between Fatigue and Inflammation, Disease Duration, and Chronic Pain in Psoriatic Arthritis: An Observational DANBIO Registry Study
Marie Skougaard, Tanja Schjødt Jørgensen, Signe Rifbjerg-Madsen, et al.
The Lancet. Rheumatology
|
January 27, 2024
Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study
Peter Nash, Laura C Coates, Dona Fleishaker, et al.
Rheumatology (Oxford, England)
|
July 1, 2026
Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights from FOREMOST
Laura C Coates, Dafna D Gladman, Joseph F Merola, et al.
The Journal of Rheumatology
|
March 2, 2021
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study
William Tillett, Oliver FitzGerald, Laura C Coates, et al.
The Journal of Rheumatology
|
July 9, 2008
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review
Laura C Coates, R Rox Anderson, Oliver Fitzgerald, et al.
Page
of 35
Search research articles
Search
Showing results (241-250 of 343) with videos related to
Sort By:
Page
of 35
The Journal of Rheumatology. Supplement
|
June 2, 2021
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study
William Tillett, Oliver FitzGerald, Laura C Coates, et al.
The Journal of Rheumatology
|
March 2, 2021
Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study
William Tillett, Oliver FitzGerald, Laura C Coates, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2020
Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps
William Tillett, Neil McHugh, Ana-Maria Orbai, et al.
ACR Open Rheumatology
|
May 19, 2026
Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies
Laure Gossec, William Tillett, Laura C Coates, et al.
Current Rheumatology Reports
|
March 14, 2014
Patient involvement in outcome measures for psoriatic arthritis
William Tillett, Ade Adebajo, Mel Brooke, et al.
The Journal of Rheumatology
|
July 17, 2019
Relationship Between Fatigue and Inflammation, Disease Duration, and Chronic Pain in Psoriatic Arthritis: An Observational DANBIO Registry Study
Marie Skougaard, Tanja Schjødt Jørgensen, Signe Rifbjerg-Madsen, et al.
The Lancet. Rheumatology
|
January 27, 2024
Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study
Peter Nash, Laura C Coates, Dona Fleishaker, et al.
Rheumatology (Oxford, England)
|
July 1, 2026
Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights from FOREMOST
Laura C Coates, Dafna D Gladman, Joseph F Merola, et al.
The Journal of Rheumatology
|
March 2, 2021
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study
William Tillett, Oliver FitzGerald, Laura C Coates, et al.
The Journal of Rheumatology
|
July 9, 2008
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review
Laura C Coates, R Rox Anderson, Oliver Fitzgerald, et al.
Page
of 35